Assessment of in vitro antimicrobial activities of ceftolozane/tazobactam and ceftazidime/avibactam against carbapenem-resistant Pseudomonas aeruginosa clinical isolates

Abstract Background Carbapenem resistant Pseudomonas aeruginosa (P. aeruginosa) is a global health concern that poses a challenge to treat in health care facilities. Ceftazidim/avibactam and ceftolozane/tazobactam have a potential role in treatment of multi-drug resistant phenotypes including carbap...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Dalia Salem, Ahmed El-Shenawy, Heba Dahroug, Manar Zaiton, Doaa Gamal, Manal Diab
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	BMC 2025-04-01
Cyfres:	BMC Infectious Diseases
Pynciau:	Carbapenem resistant P. aeruginosa Modified carbapenem inactivation method test Ceftazidim/avibactam Ceftolozane/tazobactam β-Lactam/β-Lactamase inhibitor combinations
Mynediad Ar-lein:	https://doi.org/10.1186/s12879-025-10891-w
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!